Published in BJU Int on May 01, 2007
Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. J Urol (2008) 1.37
Diffusion-weighted imaging of focal renal lesions: a meta-analysis. Eur Radiol (2013) 0.91
Imaging findings of common benign renal tumors in the era of small renal masses: differential diagnosis from small renal cell carcinoma: current status and future perspectives. Korean J Radiol (2015) 0.89
Small renal masses: surgery or surveillance. Korean J Urol (2013) 0.85
To biopsy a small renal mass, or not? Nephrourol Mon (2012) 0.83
Multi-colour FISH on preoperative renal tumour biopsies to confirm the diagnosis of uncertain renal masses. World J Urol (2010) 0.82
The contemporary role of renal mass biopsy in the management of small renal tumors. Front Oncol (2012) 0.81
Contrast enhanced ultrasound of renal masses. World J Radiol (2010) 0.81
The role of pathology in small renal mass laparoscopic cryoablation. Adv Urol (2012) 0.81
Management of small renal masses: a review. World J Urol (2010) 0.80
Surveillance as an option for the treatment of small renal masses. Adv Urol (2008) 0.79
Gender differences in benign renal masses. World J Urol (2013) 0.78
Acoustic radiation force impulse elastography in differentiating renal solid masses: a preliminary experience. Int J Clin Exp Pathol (2014) 0.77
Radiofrequency ablation: a minimally invasive approach in kidney tumor management. Cancers (Basel) (2010) 0.75
The role of renal biopsy in small renal masses. Can Urol Assoc J (2016) 0.75
Natural history and management of small renal masses. Curr Oncol (2009) 0.75
Improving needle biopsy accuracy in small renal mass using tumor-specific DNA methylation markers. Oncotarget (2016) 0.75
Surveillance for the management of small renal masses. Adv Urol (2008) 0.75
Accuracy of multi-detector computed tomography (MDCT) in staging of renal cell carcinoma (RCC): analysis of risk factors for mis-staging and its impact on surgical intervention. World J Urol (2011) 0.75
CT fluoroscopy-guided renal tumour cutting needle biopsy: retrospective evaluation of diagnostic yield, safety, and risk factors for diagnostic failure. Eur Radiol (2017) 0.75
Nonlinear 3-D simulation of high-intensity focused ultrasound therapy in the Kidney. Conf Proc IEEE Eng Med Biol Soc (2016) 0.75
Effect of dutasteride on the risk of prostate cancer. N Engl J Med (2010) 12.78
Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol (2011) 3.14
Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how? Eur Urol (2008) 2.97
The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Res (2012) 2.94
Novel artificial neural network for early detection of prostate cancer. J Clin Oncol (2002) 2.88
ConsensusPathDB: toward a more complete picture of cell biology. Nucleic Acids Res (2010) 2.79
ConsensusPathDB--a database for integrating human functional interaction networks. Nucleic Acids Res (2008) 2.77
Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol (2006) 2.77
A gene expression map of human chromosome 21 orthologues in the mouse. Nature (2002) 2.76
Computational analysis of genome-wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage. Genome Res (2010) 2.61
Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol (2009) 2.55
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy. Eur Urol (2008) 2.48
Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram. Eur Urol (2009) 2.45
Rapid extracorporeal shock wave lithotripsy for proximal ureteral calculi in colic versus noncolic patients. Eur Urol (2007) 2.41
Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol (2007) 2.39
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol (2007) 2.37
Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur Urol (2009) 2.37
Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome Res (2004) 2.29
Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol (2006) 2.29
Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. BMC Med Genomics (2011) 2.24
Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells (2006) 2.18
Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer. Urology (2009) 2.17
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology (2005) 2.10
A prospective evaluation of pain associated with stone passage, stents, and stent removal using a visual analog scale. Urology (2013) 2.05
Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res (2004) 2.03
Color Doppler sonography reliably identifies testicular torsion in boys. Urology (2009) 1.95
Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol (2009) 1.92
DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer. Eur Urol (2004) 1.89
Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology (2004) 1.82
Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial. J Urol (2004) 1.82
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay. Eur Urol (2012) 1.81
Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma of the bladder. Eur Urol (2009) 1.79
The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol (2011) 1.71
Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol (2011) 1.71
Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients. N Engl J Med (2002) 1.69
Primary differentiation in the human blastocyst: comparative molecular portraits of inner cell mass and trophectoderm cells. Stem Cells (2005) 1.68
Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. Radiology (2007) 1.67
New evidence for genome-wide duplications at the origin of vertebrates using an amphioxus gene set and completed animal genomes. Genome Res (2003) 1.65
Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol (2004) 1.65
Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms. Eur Urol (2013) 1.65
Kidney fusion anomalies revisited: clinical and radiological analysis of 209 cases of crossed fused ectopia and horseshoe kidney. BJU Int (2008) 1.61
Perioperative morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a European multicentre experience. Eur Urol (2009) 1.60
Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab Invest (2003) 1.60
Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men. Prostate (2002) 1.56
Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol (2012) 1.54
Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis. Urology (2002) 1.51
Local active warming: an effective treatment for pain, anxiety and nausea caused by renal colic. J Urol (2003) 1.50
Hypothyroidism in patients with renal cell carcinoma: blessing or curse? Cancer (2010) 1.50
Perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: a matched pair analysis. J Endourol (2011) 1.49
Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology (2005) 1.48
Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA. Bioinformatics (2011) 1.46
Prospective randomized multicenter study comparing prostate cancer detection rates of end-fire and side-fire transrectal ultrasound probe configuration. Urology (2012) 1.46
Reduction in the risk of prostate cancer: future directions after the Prostate Cancer Prevention Trial. Urology (2009) 1.45
Androgen deficiency symptoms in testicular cancer survivors are associated with sexual problems but not with serum testosterone or therapy. Urology (2009) 1.41
c-kit overexpression in chromophobe renal cell carcinoma is not associated with c-kit mutation of exons 9 and 11. Am J Surg Pathol (2005) 1.39
High-risk human papilloma virus infection of the foreskin in asymptomatic boys. Urology (2013) 1.39
Open to debate. The motion: GnRH antagonists are the new way forward in hormonal therapy. Eur Urol (2009) 1.38
MEDIPS: genome-wide differential coverage analysis of sequencing data derived from DNA enrichment experiments. Bioinformatics (2013) 1.38
Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr Opin Urol (2006) 1.38
Cardiopulmonary resuscitation-associated major liver injury. Resuscitation (2007) 1.33
Treatment of localised renal cell carcinoma. Eur Urol (2011) 1.29
The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol (2005) 1.29
Proteomic and functional analysis of the mitotic Drosophila centrosome. EMBO J (2010) 1.27
Reverse engineering of gene regulatory networks: a comparative study. EURASIP J Bioinform Syst Biol (2009) 1.22
US-guided 14-gauge core-needle breast biopsy: results of a validation study in 1352 cases. Radiology (2008) 1.20
Evidence mining and novelty assessment of protein-protein interactions with the ConsensusPathDB plugin for Cytoscape. Bioinformatics (2010) 1.19
Contemporary management of small renal masses. Eur Urol (2011) 1.19
p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol (2003) 1.19
A global view of gene expression in lithium and zinc treated sea urchin embryos: new components of gene regulatory networks. Genome Biol (2007) 1.19
Prostate cancer in elderly men. Rev Urol (2008) 1.19
[The first autochthonous case of subcutaneous dirofilariosis in Austria]. Wien Klin Wochenschr (2008) 1.18
Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. J Urol (2013) 1.18
A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results. Invest Radiol (2009) 1.17
State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology (2004) 1.17